Literature DB >> 23506370

Cigarette smoking in methadone maintained patients: an up-to-date review.

Ali Zirakzadeh1, Charles Shuman, Erinn Stauter, J Taylor Hays, Jon O Ebbert.   

Abstract

Tobacco dependence is the leading cause of preventable death and disability in the United States. While smoking prevalence among U.S. adults is 19.3%, the prevalence of smoking among methadone-maintained patients ranges between 73.5% and 94%. Most methadone-maintained smokers (76%-80%) desire to quit smoking; however only a minority of these smokers receive cessation treatment or referrals for smoking cessation intervention. Smoking cessation treatment in methadone-maintained patients has generally been successful in reducing the daily number of cigarettes smoked. Unfortunately, sustained cessation rates using nicotine replacement therapy and behavioral interventions have generally been low (0%-11%). Poor cessation outcomes may be partially explained by pharmacodynamic interactions between nicotine and methadone leading to increased reinforcement of smoking behavior. Further research is needed to improve smoking cessation rates in methadone-maintained patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23506370     DOI: 10.2174/1874473711306010009

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  24 in total

1.  Early quit days among methadone-maintained smokers in a smoking cessation trial.

Authors:  Marcel A de Dios; Bradley J Anderson; Celeste M Caviness; Michael D Stein
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

Review 2.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 3.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

4.  Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment.

Authors:  Stephen R Baldassarri; David A Fiellin; Mary Ellen Savage; Lynn M Madden; Mark Beitel; Lara K Dhingra; Lisa Fucito; Deepa Camenga; Pooja Bollampally; Declan T Barry
Journal:  Drug Alcohol Depend       Date:  2019-01-17       Impact factor: 4.492

Review 5.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

6.  Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.

Authors:  Nina A Cooperman; Shou-En Lu; Kimber P Richter; Steven L Bernstein; Jill M Williams
Journal:  Nicotine Tob Res       Date:  2018-08-14       Impact factor: 4.244

7.  Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain.

Authors:  Martin D Cheatle; Mary Falcone; Lara Dhingra; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2020-02-14       Impact factor: 4.492

8.  Influence of Psychiatric and Personality Disorders on Smoking Cessation Among Individuals in Opiate Dependence Treatment.

Authors:  Nina A Cooperman; Shou-En Lu; Kimber P Richter; Steven L Bernstein; Jill M Williams
Journal:  J Dual Diagn       Date:  2016-04-11

9.  Effects of tobacco on affect and craving during opioid addiction recovery: An ecological momentary assessment study.

Authors:  Blythe E Rhodes; Nisha C Gottfredson
Journal:  Addict Behav       Date:  2020-02-17       Impact factor: 3.913

10.  Tobacco withdrawal among opioid-dependent smokers.

Authors:  Joanna M Streck; Sarah H Heil; Stephen T Higgins; Janice Y Bunn; Stacey C Sigmon
Journal:  Exp Clin Psychopharmacol       Date:  2018-02-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.